1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow non-verbal learning disabilities: new trials by email Literature Review of non-verbal learning disabilities trials Research Report on non-verbal learning disabilities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions Memantine Hydrochloride, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Terminated | Massachusetts General Hospital | 25 | 2018-11-13 | 2026-02-25 |
Autism Spectrum Disorder (1) · Autistic Disorder (1)
Child Development Disorders, Pervasive (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1)
Memantine (1)
Massachusetts General Hospital (1)
United States (1)
Gagan Joshi, MD (1)